Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (51-60 of 917) with videos related to

Pageof 92
Sort By:
Aktuelle Urologie|June 15, 2007
[Pro and contra: 11C choline PET in diagnosis of prostate cancer]Jörg Kotzerke, Klaus Zöphel, Georg Salomon, et al.
Internet Interventions|August 24, 2018
Effectiveness, acceptance and satisfaction of guided chat groups in psychosocial aftercare for outpatients with prostate cancer after prostatectomyLukas Lange, Juliane Fink, Christiane Bleich, et al.
BJU International|September 10, 2008
Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancerAndreas Erbersdobler, Jens Kollermann, Markus Graefen, et al.
Urologic Oncology|March 28, 2015
The effect of age on functional outcomes after radical prostatectomyPhilipp Mandel, Markus Graefen, Uwe Michl, et al.
European Urology Oncology|August 4, 2023
Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node DissectionPierre I Karakiewicz, Reha-Baris Incesu, Lukas Scheipner, et al.
European Urology|April 9, 2019
External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European CohortDerya Tilki, Felix Preisser, Markus Graefen, et al.
World Journal of Urology|March 3, 2007
Role of nomograms for prostate cancer in 2007Felix K-H Chun, Pierre I Karakiewicz, Hartwig Huland, et al.
European Urology|November 15, 2025
Shaping the Future of Positive Surgical Margins During Radical Prostatectomy: Are New Technologies Here To Stay?Greg L Shaw, Geert J L H van Leenders, Markus Graefen
BJU International|December 22, 2004
Prostate cancers in the transition zone: Part 2; clinical aspectsHerbert Augustin, Andreas Erbersdobler, Peter G Hammerer, et al.
The Prostate|April 3, 2018
Reply to the letter to the editor: RE: Preisser F, et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018;1-7Felix Preisser, Marco Bandini, Markus Graefen, et al.
Pageof 92

Showing results (51-60 of 917) with videos related to

Sort By:
Pageof 92
Aktuelle Urologie|June 15, 2007
[Pro and contra: 11C choline PET in diagnosis of prostate cancer]Jörg Kotzerke, Klaus Zöphel, Georg Salomon, et al.
Internet Interventions|August 24, 2018
Effectiveness, acceptance and satisfaction of guided chat groups in psychosocial aftercare for outpatients with prostate cancer after prostatectomyLukas Lange, Juliane Fink, Christiane Bleich, et al.
BJU International|September 10, 2008
Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancerAndreas Erbersdobler, Jens Kollermann, Markus Graefen, et al.
Urologic Oncology|March 28, 2015
The effect of age on functional outcomes after radical prostatectomyPhilipp Mandel, Markus Graefen, Uwe Michl, et al.
European Urology Oncology|August 4, 2023
Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node DissectionPierre I Karakiewicz, Reha-Baris Incesu, Lukas Scheipner, et al.
European Urology|April 9, 2019
External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European CohortDerya Tilki, Felix Preisser, Markus Graefen, et al.
World Journal of Urology|March 3, 2007
Role of nomograms for prostate cancer in 2007Felix K-H Chun, Pierre I Karakiewicz, Hartwig Huland, et al.
European Urology|November 15, 2025
Shaping the Future of Positive Surgical Margins During Radical Prostatectomy: Are New Technologies Here To Stay?Greg L Shaw, Geert J L H van Leenders, Markus Graefen
BJU International|December 22, 2004
Prostate cancers in the transition zone: Part 2; clinical aspectsHerbert Augustin, Andreas Erbersdobler, Peter G Hammerer, et al.
The Prostate|April 3, 2018
Reply to the letter to the editor: RE: Preisser F, et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018;1-7Felix Preisser, Marco Bandini, Markus Graefen, et al.
Pageof 92